SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-165712
Filing Date
2024-06-21
Accepted
2024-06-21 16:23:28
Documents
7
Period of Report
2024-08-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A d802241ddef14a.htm DEF 14A 1281698
2 GRAPHIC g802241g00r01.jpg GRAPHIC 25425
3 GRAPHIC g802241g00r41.jpg GRAPHIC 43591
4 GRAPHIC g802241g00r42.jpg GRAPHIC 42819
5 GRAPHIC g802241g01l07.jpg GRAPHIC 25741
6 GRAPHIC g802241g19p19.jpg GRAPHIC 224220
7 GRAPHIC g802241g20p20.jpg GRAPHIC 316366
  Complete submission text file 0001193125-24-165712.txt   2216790
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37627 | Film No.: 241060748
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)